Search results for: 'Cancer Diagnostics Market'

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

08 Feb 2023  |  North America  |  Market Research

Growth Opportunities in the Global Cloud-based Medical Imaging Informatics Market, Forecast to 2026

Conventional Medical Imaging Informatics Shifts to AI-based Consolidated Solutions

Infographics

×

Medical imaging informatics solution deployment is shifting from the on-premises model to a cloud-based infrastructure. The conventional on-premises model, which requires every enterprise to buy, operate, and maintain its own cumbersome IT infrastructure and solutions, proves unsustainable in the era of big data. It is also short-sighted given the ...

01 Aug 2018  |  Europe  |  Market Research

Analysis of Western European Molecular Imaging Market, Forecast to 2022

Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve

Infographics

×

This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux. The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence o...

15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...

Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional rad...

14 Feb 2020  |  Asia Pacific  |  Market Research

Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

Infographics

×

This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

This insight presents an analysis of the global breast ultrasound market. It provides an in-depth analysis of the current trends, market size, revenue forecast, market penetration, and market attractiveness, both in the conventional and automated breast ultrasound market. X-ray Mammography is the gold standard for breast cancer detection. Due to ...